Consult
Log In
Menu
Consult
Log in

by Josh Forsythe, on April 5, 2018

In case you missed it, PierianDx customer, Inova, is launching a joint study with the National Institutes of Health (NIH) to “re-engineer” genomics. The study, called the Genomic Ascertainment Cohort (TGAC), …

Read Story
Topics:News

by Josh Forsythe, on April 3, 2018

The drive to deliver precision medicine has galvanized many hospitals to in-source next generation sequencing (NGS) testing. Yet for hospital labs just getting started, the process can be overwhelming. They …

Read Story
Topics:News

by Josh Forsythe, on March 28, 2018

Life gets better when we enter our "golden years" and retire, doesn’t it? Not necessarily. Because we are living longer, we face the possibility of living with an age-related chronic …

Read Story
Topics:News

by Josh Forsythe, on March 26, 2018

The Moffitt Morsani Molecular Laboratory, located within the Moffitt Cancer Center, announced today that it has launched a new clinical NGS assay, Solid Tumor Actionable Result, or STAR. STAR is based …

Read Story
Topics:News

by Josh Forsythe, on March 26, 2018

PierianDx will be highlighting germline features of its genomics technology platform the American College of Medical Genetics and Genomics (ACMG) annual meeting April 10-14 in Charlotte, North Carolina. Representatives from …

Read Story
Topics:News

by Josh Forsythe, on March 23, 2018

When CMS initiated a national coverage analysis for NGS-based testing for advanced cancer on November 30, 2017, it stirred up a lot of debate among the leaders in precision medicine, …

Read Story
Topics:CMS NCD on Genomic TestingNews

by Josh Forsythe, on March 19, 2018

We are excited to attend the upcoming Precision Oncology Experimental Therapeutics (POET) Congress in Calgary, Alberta the first week in April. We will have an opportunity to collaborate with precision …

Read Story
Topics:News

by Josh Forsythe, on March 16, 2018

On April 5 and 6 oncology leaders will convene in Calgary, Alberta to participate in the 2nd International Precision Oncology and Experimental Therapeutics (POET) Congress. The annual meeting supports the …

Read Story
Topics:News

by Josh Forsythe, on March 16, 2018

Genetic diseases are the leading cause of death for infants in North America, affecting an estimated 4 percent of newborns. In MIT Technology Review, Rady Children’s Hospital in San Diego …

Read Story
Topics:News

by Josh Forsythe, on March 16, 2018

Laura J. Tafe, MD, associate professor of pathology and laboratory medicine at Geisel School of Medicine at Dartmouth, and assistant director of the Laboratory for Clinical Genomics and Advanced Technologies, …

Read Story
Topics:News

by Josh Forsythe, on March 15, 2018

While healthcare continues to improve, advances in technologies and treatments have also made it more complex. It’s estimated that nearly 100,000 patients die every year due to medical errors [1] …

Read Story
Topics:News

by PierianDx, on March 14, 2018

by Brad Herrick, PierianDx Like most people who have been going to HIMSS for some time, both as an attendee and sponsor, I have been inspired by the hope of …

Read Story
Topics:News